Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bromocriptine in Parkinsonism.

I Pearce, J M Pearce

    British Medical Journal
    |May 27, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Bromocriptine offers limited benefit for Parkinson's disease patients not responding to levodopa. However, it can be effective when combined with levodopa for patients experiencing late-stage treatment decline, despite high costs and psychosis risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Low-cost embedded system for spectral power distribution reconstruction for controlled environmental agriculture using a multispectral sensor and cloud-based deep learning.

    HardwareX·2026
    Same author

    An open-source spectral measurement platform for plant reflectance and material identification.

    HardwareX·2026
    Same author

    Open-source 3-D printable autoinjector: Design, testing, and regulatory limitations.

    PloS one·2023
    Same author

    Open source surgical fracture table for digitally distributed manufacturing.

    PloS one·2022
    Same author

    Overcoming supply disruptions during pandemics by utilizing found hardware for open source gentle ventilation.

    HardwareX·2022
    Same author

    Open source software toolchain for automated non-targeted screening for toxins in alternative foods.

    MethodsX·2021
    Same journal

    Muscular pain during therapy with carbenoxolone (Biogastrone).

    British medical journal·2016
    Same journal

    ACUTE INTESTINAL OBSTRUCTION DUE TO INTRA-ABDOMINAL CAUSES.

    British medical journal·2014
    Same journal

    A CASE OF HAEMATIDROSIS.

    British medical journal·2014
    Same journal

    Incidence of ulcer in haematemesis.

    British medical journal·2011
    Same journal

    Pituitary hypothyroidism with impaired renal function.

    British medical journal·2011
    Same journal

    The fenestration operation for otosclerosis.

    British medical journal·2011
    See all related articles

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Parkinson's disease (PD) is a progressive neurodegenerative disorder.
    • Levodopa is a primary treatment for PD, but its efficacy can decline over time.

    Purpose of the Study:

    • To review the efficacy and limitations of bromocriptine in Parkinson's disease management.
    • To identify patient subgroups that may benefit from bromocriptine therapy.

    Main Methods:

    • Systematic review of existing literature on bromocriptine use in Parkinson's disease.
    • Analysis of treatment outcomes based on patient response to levodopa.

    Main Results:

    • Bromocriptine shows minimal benefit for patients not primarily improved by levodopa.
    • Combination therapy with bromocriptine and levodopa benefits patients with late-stage levodopa failure and declining response.

    Related Experiment Videos

  • High cost and risk of severe psychosis are significant drawbacks of bromocriptine.

    • Conclusions:

    • Bromocriptine is not recommended for PD patients well-managed on levodopa alone.
    • Bromocriptine is the optimal available drug for hospitalized patients with late-stage levodopa failure.
    • Careful patient selection is crucial due to bromocriptine's adverse effects.